Date: 1st June 2017
Location: Paris, France
Preventing Malaria Mortality : a vaccine solution
Malaria vaccine development has reached a remarkable turning point. One candidate vaccine has completed a 16,000 subject phase III trial with mixed results but is aiming for licensure, another whole parasite approach has shown high level efficacy in the US but much less efficacy in Africa, and the first four-stage malaria vaccine is approaching African trials.
For more information, please visit: https://research.pasteur.fr/en/event/new-malaria-vaccines/